Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia von Ehninger, A, Kramer, M, Röllig, C, Thiede, C, Bornhäuser, M, von Bonin, M, Wermke, M, Feldmann, A, Bachmann, M, Ehninger, G, Oelschlägel, U

Volltext

Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts von Cartellieri, M, Feldmann, A, Koristka, S, Arndt, C, Loff, S, Ehninger, A, von Bonin, M, Bejestani, E P, Ehninger, G, Bachmann, M P

Volltext

Clinical-grade manufacturing of switchable CAR-T cells in an automated closed system for phase I/II trials von Dietrich, J, Riewaldt, J, Loff, S, Meyer, J, Schallenberg, S, Spehr, J, Gründer, C, Franke, K, Kreissig, C, Ehninger, G, Bachmann, M, Ehninger, A, Cartellieri, M

Volltext

Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts von Aliperta, R, Cartellieri, M, Feldmann, A, Arndt, C, Koristka, S, Michalk, I, von Bonin, M, Ehninger, A, Bachmann, J, Ehninger, G, Bornhäuser, M, Bachmann, M P

Volltext

Targeting leukemia using an inducible universal chimeric antigen receptor (UniCAR) T cell technology von Dietrich, J, Loff, S, Meyer, J, von Bonin, M, Hetzenecker, M, Spehr, J, Gründer, C, Riewaldt, J, Ehninger, G, Bachmann, M.P, Ehninger, A, Cartellieri, M

Volltext

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors von Anasetti, Claudio, Logan, Brent R, Lee, Stephanie J, Waller, Edmund K, Weisdorf, Daniel J, Wingard, John R, Cutler, Corey S, Westervelt, Peter, Woolfrey, Ann, Couban, Stephen, Ehninger, Gerhard, Johnston, Laura, Maziarz, Richard T, Pulsipher, Michael A, Porter, David L, Mineishi, Shin, McCarty, John M, Khan, Shakila P, Anderlini, Paolo, Bensinger, William I, Leitman, Susan F, Rowley, Scott D, Bredeson, Christopher, Carter, Shelly L, Horowitz, Mary M, Confer, Dennis L

Volltext

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia von Hochhaus, Andreas, Larson, Richard A, Guilhot, François, Radich, Jerald P, Branford, Susan, Hughes, Timothy P, Baccarani, Michele, Deininger, Michael W, Cervantes, Francisco, Fujihara, Satoko, Ortmann, Christine-Elke, Menssen, Hans D, Kantarjian, Hagop, O’Brien, Stephen G, Druker, Brian J

Volltext

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-labe... von Schmitz, Norbert, Prof, Nickelsen, Maike, MD, Ziepert, Marita, PhD, Haenel, Mathias, MD, Borchmann, Peter, MD, Schmidt, Christian, MD, Viardot, Andreas, MD, Bentz, Martin, MD, Peter, Norma, MD, Ehninger, Gerhard, Prof, Doelken, Gottfried, Prof, Ruebe, Christian, Prof, Truemper, Lorenz, Prof, Rosenwald, Andreas, Prof, Pfreundschuh, Michael, Prof, Loeffler, Markus, Prof, Glass, Bertram, MD

Volltext

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML von Shayegi, Nona, Kramer, Michael, Bornhäuser, Martin, Schaich, Markus, Schetelig, Johannes, Platzbecker, Uwe, Röllig, Christoph, Heiderich, Caroline, Landt, Olfert, Ehninger, Gerhard, Thiede, Christian

Volltext

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes von Krug, Utz, Dr, Röllig, Christoph, MD, Koschmieder, Anja, Heinecke, Achim, PhD, Sauerland, Maria Cristina, MSc, Schaich, Markus, Prof, Thiede, Christian, Prof, Kramer, Michael, Braess, Jan, Prof, Spiekermann, Karsten, MD, Haferlach, Torsten, Prof, Haferlach, Claudia, MD, Koschmieder, Steffen, MD, Rohde, Christian, PhD, Serve, Hubert, Prof, Wörmann, Bernhard, Prof, Hiddemann, Wolfgang, Prof, Ehninger, Gerhard, Prof, Berdel, Wolfgang E, Prof, Büchner, Thomas, Prof, Müller-Tidow, Carsten, Prof

Volltext

Emerging Role of SUMO in Pancreatic β-Cells von Ehninger, A., Mziaut, H., Solimena, M.

Volltext

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study von Fleischhauer, Katharina, MD, Shaw, Bronwen E, Dr, Gooley, Theodore, Prof, Malkki, Mari, PhD, Bardy, Peter, MD, Bignon, Jean-Denis, MD, Dubois, Valérie, BSc, Horowitz, Mary M, Prof, Madrigal, J Alejandro, Prof, Morishima, Yasuo, Prof, Oudshoorn, Machteld, PhD, Ringden, Olle, Prof, Spellman, Stephen, MBS, Velardi, Andrea, Prof, Zino, Elisabetta, BSc, Petersdorf, Effie W, Prof

Volltext

High-risk additional chromosomal abnormalities at low blast counts herald death by CML von Hehlmann, Rüdiger, Voskanyan, Astghik, Lauseker, Michael, Pfirrmann, Markus, Kalmanti, Lida, Rinaldetti, Sebastien, Kohlbrenner, Katharina, Haferlach, Claudia, Schlegelberger, Brigitte, Fabarius, Alice, Seifarth, Wolfgang, Spieß, Birgit, Wuchter, Patrick, Krause, Stefan, Kolb, Hans-Jochem, Neubauer, Andreas, Hossfeld, Dieter K., Nerl, Christoph, Gratwohl, Alois, Baerlocher, Gabriela M., Burchert, Andreas, Brümmendorf, Tim H., Hasford, Jörg, Hochhaus, Andreas, Saußele, Susanne, Baccarani, Michele

Volltext

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia von Hochhaus, A, O'Brien, S G, Guilhot, F, Druker, B J, Branford, S, Foroni, L, Goldman, J M, Müller, M C, Radich, J P, Rudoltz, M, Mone, M, Gathmann, I, Hughes, T P, Larson, R A

Volltext

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study von Larson, Richard A., Druker, Brian J., Guilhot, Francois, O'Brien, Stephen G., Riviere, Gilles J., Krahnke, Tillmann, Gathmann, Insa, Wang, Yanfeng

Volltext

The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia von Seifert, H, Mohr, B, Thiede, C, Oelschlägel, U, Schäkel, U, Illmer, T, Soucek, S, Ehninger, G, Schaich, M

Volltext

Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia von Müller-Tidow, Carsten, Klein, Hans-Ulrich, Hascher, Antje, Isken, Fabienne, Tickenbrock, Lara, Thoennissen, Nils, Agrawal-Singh, Shuchi, Tschanter, Petra, Disselhoff, Christine, Wang, Yipeng, Becker, Anke, Thiede, Christian, Ehninger, Gerhard, zur Stadt, Udo, Koschmieder, Steffen, Seidl, Matthias, Müller, Frank U., Schmitz, Wilhelm, Schlenke, Peter, McClelland, Michael, Berdel, Wolfgang E., Dugas, Martin, Serve, Hubert

Volltext

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study von Gattermann, Norbert, Finelli, Carlo, Porta, Matteo Della, Fenaux, Pierre, Ganser, Arnold, Guerci-Bresler, Agnes, Schmid, Mathias, Taylor, Kerry, Vassilieff, Dominique, Habr, Dany, Domokos, Gabor, Roubert, Bernard, Rose, Christian

Volltext

304 - Clinical-grade manufacturing of switchable CAR-T cells in an automated closed system for phase I/II trials von Dietrich, J., Riewaldt, J., Loff, S., Meyer, J., Schallenberg, S., Spehr, J., Gründer, C., Franke, K., Kreissig, C., Ehninger, G., Bachmann, M., Ehninger, A., Cartellieri, M.

Volltext

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase von Kantarjian, Hagop M., Larson, Richard A., Guilhot, Francois, O'Brien, Stephen G., Mone, Manisha, Rudoltz, Marc, Krahnke, Tillmann, Cortes, Jorge, Druker, Brian J.

Volltext